The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma
Open accessAbstract
T cells are expanded and express GZMK/B. Our data suggest nivolumab drives both maintenance and replacement of previously expanded T cell clones, but only maintenance correlates with response. We hypothesize that maintenance and boosting of a pre-existing response is a key element of anti-PD-1 mode of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
BLAST+: architecture and applications
Camacho, C., Coulouris, G., Avagyan, V., Ma, N., Papadopoulos, J., Bealer, K., & Madden, T. L. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-421 · Cited by 22,074
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype
Kim, D., Paggi, J. M., Park, C., Bennett, C., & Salzberg, S. L. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0201-4 · Cited by 15,022
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,621
Robust enumeration of cell subsets from tissue expression profiles
Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., Hoang, C. D., Diehn, M., & Alizadeh, A. A. (2015) · Nature Methods · doi:10.1038/nmeth.3337 · Cited by 13,224
Fast, sensitive and accurate integration of single-cell data with Harmony
Korsunsky, I., Millard, N., Fan, J., Slowikowski, K., Zhang, F., Wei, K., Baglaenko, Y., Brenner, M., Loh, P.-R., & Raychaudhuri, S. (2019) · Nature Methods · doi:10.1038/s41592-019-0619-0 · Cited by 10,488
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Rizvi, N. A., Hellmann, M. D., Snyder, A., Kvistborg, P., Makarov, V., Havel, J. J., Lee, W., Yuan, J., Wong, P., Ho, T. S., et al. (2015) · Science · doi:10.1126/science.aaa1348 · Cited by 7,802
Massively parallel digital transcriptional profiling of single cells
Zheng, G. X. Y., Terry, J. M., Belgrader, P., Ryvkin, P., Bent, Z. W., Wilson, R., Ziraldo, S. B., Wheeler, T. D., McDermott, G. P., Zhu, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14049 · Cited by 7,353
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science · doi:10.1126/science.aan6733 · Cited by 6,645
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Motzer, R. J., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510665 · Cited by 5,807
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D., Sougnez, C., Gabriel, S., Meyerson, M., Lander, E. S., & Getz, G. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,981
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Motzer, R. J., Tannir, N. M., McDermott, D. F., Arén Frontera, O., Melichar, B., Choueiri, T. K., Plimack, E. R., Barthélémy, P., Porta, C., George, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1712126 · Cited by 4,656
Hafemeister, C., & Satija, R. (2019) · Genome Biology · doi:10.1186/s13059-019-1874-1 · Cited by 4,479
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Snyder, A., Makarov, V., Merghoub, T., Yuan, J., Zaretsky, J. M., Desrichard, A., Walsh, L. A., Postow, M. A., Wong, P., Ho, T. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406498 · Cited by 4,286
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
Molecular and genetic properties of tumors associated with local immune cytolytic activity
Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., & Hacohen, N. (2015) · Cell · doi:10.1016/j.cell.2014.12.033 · Cited by 3,825
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
Zaretsky, J. M., Garcia-Diaz, A., Shin, D. S., Escuin-Ordinas, H., Hugo, W., Hu-Lieskovan, S., Torrejon, D. Y., Abril-Rodriguez, G., Sandoval, S., Barthly, L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604958 · Cited by 3,237
Finak, G., McDavid, A., Yajima, M., Deng, J., Gersuk, V., Shalek, A. K., Slichter, C. K., Miller, H. W., McElrath, M. J., Prlic, M., et al. (2015) · Genome Biology · doi:10.1186/s13059-015-0844-5 · Cited by 3,159
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Wei, S. C., Duffy, C. R., & Allison, J. P. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0367 · Cited by 3,088
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
McGranahan, N., Furness, A. J. S., Rosenthal, R., Ramskov, S., Lyngaa, R., Saini, S. K., Jamal-Hanjani, M., Wilson, G. A., Birkbak, N. J., Hiley, C. T., et al. (2016) · Science · doi:10.1126/science.aaf1490 · Cited by 3,065
Self-citationBrahmer, J. R., Drake, C. G., Wollner, I., Powderly, J. D., Picus, J., Sharfman, W. H., Stankevich, E., Pons, A., Salay, T. M., McMiller, T. L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7609 · Cited by 2,961
B cells and tertiary lymphoid structures promote immunotherapy response
Helmink, B. A., Reddy, S. M., Gao, J., Zhang, S., Basar, R., Thakur, R., Yizhak, K., Sade-Feldman, M., Blando, J., Han, G., et al. (2020) · Nature · doi:10.1038/s41586-019-1922-8 · Cited by 2,731
Self-citationAvelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Motzer, R. J., Penkov, K., Haanen, J., Rini, B., Albiges, L., Campbell, M. T., Venugopal, B., Kollmannsberger, C., Negrier, S., Uemura, M., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1816047 · Cited by 2,503
Self-citationDong, H., Zhu, G., Tamada, K., & Chen, L. (1999) · Nature Medicine · doi:10.1038/70932 · Cited by 2,496
Slide-seq: A scalable technology for measuring genome-wide expression at high spatial resolution
Rodriques, S. G., Stickels, R. R., Goeva, A., Martin, C. A., Murray, E., Vanderburg, C. R., Welch, J., Chen, L. M., Chen, F., & Macosko, E. Z. (2019) · Science · doi:10.1126/science.aaw1219 · Cited by 2,424
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Riaz, N., Havel, J. J., Makarov, V., Desrichard, A., Urba, W. J., Sims, J. S., Hodi, F. S., Martín-Algarra, S., Mandal, R., Sharfman, W. H., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.028 · Cited by 2,401
The immune contexture in cancer prognosis and treatment
Fridman, W. H., Zitvogel, L., Sautès–Fridman, C., & Kroemer, G. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.101 · Cited by 2,263
Heng, D. Y. C., Xie, W., Regan, M. M., Warren, M. A., Golshayan, A. R., Sahi, C., Eigl, B. J., Ruether, J. D., Cheng, T., North, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.4809 · Cited by 2,133
CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing
Talevich, E., Shain, A. H., Botton, T., & Bastian, B. C. (2016) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004873 · Cited by 2,094
Miller, B. C., Sen, D. R., Al Abosy, R., Bi, K., Virkud, Y. V., LaFleur, M. W., Yates, K. B., Lako, A., Felt, K., Naik, G. S., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0312-6 · Cited by 2,087
Absolute quantification of somatic DNA alterations in human cancer
Carter, S. L., Cibulskis, K., Helman, E., McKenna, A., Shen, H., Zack, T., Laird, P. W., Onofrio, R. C., Winckler, W., Weir, B. A., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2203 · Cited by 2,053
B cells are associated with survival and immunotherapy response in sarcoma
Petitprez, F., de Reyniès, A., Keung, E. Z., Chen, T. W.-W., Sun, C.-M., Calderaro, J., Jeng, Y.-M., Hsiao, L.-P., Lacroix, L., Bougoüin, A., et al. (2020) · Nature · doi:10.1038/s41586-019-1906-8 · Cited by 1,942
kernlab- An S4 Package for Kernel Methods in R
Karatzoglou, A., Smola, A., Hornik, K., & Zeileis, A. (2004) · Journal of Statistical Software · doi:10.18637/jss.v011.i09 · Cited by 1,786
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Huang, A. C., Postow, M. A., Orlowski, R. J., Mick, R., Bengsch, B., Manne, S., Xu, W., Harmon, S., Giles, J. R., Wenz, B., et al. (2017) · Nature · doi:10.1038/nature22079 · Cited by 1,664
Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing
Guo, X., Zhang, Y., Zheng, L., Zheng, C., Song, J., Zhang, Q., Kang, B., Liu, Z., Jin, L., Xing, R., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0045-3 · Cited by 1,651
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Khan, O., Giles, J. R., McDonald, S., Manne, S., Ngiow, S. F., Patel, K. P., Werner, M. T., Huang, A. C., Alexander, K. A., Wu, J. E., et al. (2019) · Nature · doi:10.1038/s41586-019-1325-x · Cited by 1,646
Clonal replacement of tumor-specific T cells following PD-1 blockade
Yost, K. E., Satpathy, A. T., Wells, D. K., Qi, Y., Wang, C., Kageyama, R., McNamara, K. L., Granja, J. M., Sarin, K. Y., Brown, R. A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0522-3 · Cited by 1,534
Lineage tracking reveals dynamic relationships of T cells in colorectal cancer
Zhang, L., Yu, X., Zheng, L., Zhang, Y., Li, Y., Fang, Q., Gao, R., Kang, B., Zhang, Q., Huang, J. Y., et al. (2018) · Nature · doi:10.1038/s41586-018-0694-x · Cited by 1,505
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Simoni, Y., Becht, E., Fehlings, M., Loh, C. Y., Koo, S.-L., Teng, K. W. W., Yeong, J. P. S., Nahar, R., Zhang, T., Kared, H., et al. (2018) · Nature · doi:10.1038/s41586-018-0130-2 · Cited by 1,370
VarScan: variant detection in massively parallel sequencing of individual and pooled samples
Koboldt, D. C., Chen, K., Wylie, T., Larson, D. E., McLellan, M. D., Mardis, E. R., Weinstock, G. M., Wilson, R. K., & Ding, L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp373 · Cited by 1,348
Self-citationThommen, D. S., & Schumacher, T. N. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.012 · Cited by 1,299
McDermott, D. F., Huseni, M. A., Atkins, M. B., Motzer, R. J., Rini, B. I., Escudier, B., Fong, L., Joseph, R. W., Pal, S. K., Reeves, J. A., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0053-3 · Cited by 1,260
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
Miao, D., Margolis, C. A., Gao, W., Voss, M. H., Li, W., Martini, D. J., Norton, C., Bossé, D., Wankowicz, S. M., Cullen, D., et al. (2018) · Science · doi:10.1126/science.aan5951 · Cited by 1,249
Rosenthal, R., McGranahan, N., Herrero, J., Taylor, B. S., & Swanton, C. (2016) · Genome Biology · doi:10.1186/s13059-016-0893-4 · Cited by 1,216
Self-citationGerlinger, M., Horswell, S., Larkin, J., Rowan, A. J., Salm, M. P., Varela, I., Fisher, R., McGranahan, N., Matthews, N., Santos, C. R., et al. (2014) · Nature Genetics · doi:10.1038/ng.2891 · Cited by 1,208
Self-citationMapSplice: Accurate mapping of RNA-seq reads for splice junction discovery
Wang, K., Singh, D., Zeng, Z., Coleman, S. J., Huang, Y., Savich, G. L., He, X., Mieczkowski, P., Grimm, S. A., Perou, C. M., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq622 · Cited by 1,193
Thommen, D. S., Koelzer, V. H., Herzig, P., Roller, A., Trefny, M., Dimeloe, S., Kiialainen, A., Hanhart, J., Schill, C., Hess, C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0057-z · Cited by 1,161
TOX is a critical regulator of tumour-specific T cell differentiation
Scott, A. C., Dündar, F., Zumbo, P., Chandran, S. S., Klebanoff, C. A., Shakiba, M., Trivedi, P., Menocal, L., Appleby, H., Camara, S., et al. (2019) · Nature · doi:10.1038/s41586-019-1324-y · Cited by 1,106
Li, H., van der Leun, A. M., Yofe, I., Lubling, Y., Gelbard-Solodkin, D., van Akkooi, A. C. J., van den Braber, M., Rozeman, E. A., Haanen, J. B. A. G., Blank, C. U., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.043 · Cited by 1,101
Gapped sequence alignment using artificial neural networks: application to the MHC class I system
Andreatta, M., & Nielsen, M. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btv639 · Cited by 1,087
Multiplex digital spatial profiling of proteins and RNA in fixed tissue
Merritt, C. R., Ong, G. T., Church, S. E., Barker, K., Danaher, P., Geiss, G., Hoang, M., Jung, J., Liang, Y., McKay-Fleisch, J., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0472-9 · Cited by 1,072
WGS500 Consortium, Rimmer, A., Phan, H., Mathieson, I., Iqbal, Z., Twigg, S. R. F., Wilkie, A. O. M., McVean, G., & Lunter, G. (2014) · Nature Genetics · doi:10.1038/ng.3036 · Cited by 1,057
Identifying specificity groups in the T cell receptor repertoire
Glanville, J., Huang, H., Nau, A., Hatton, O., Wagar, L. E., Rubelt, F., Ji, X., Han, A., Krams, S. M., Pettus, C., et al. (2017) · Nature · doi:10.1038/nature22976 · Cited by 1,026
Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients
ROSENBERG, S. A., LOTZE, M. T., YANG, J. C., AEBERSOLD, P. M., LINEHAN, W. M., SEIPP, C. A., & WHITE, D. E. (1989) · Annals of Surgery · doi:10.1097/00000658-198910000-00008 · Cited by 1,002
Braun, D. A., Hou, Y., Bakouny, Z., Ficial, M., Sant’ Angelo, M., Forman, J., Ross-Macdonald, P., Berger, A. C., Jegede, O. A., Elagina, L., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0839-y · Cited by 992
Neoantigen-directed immune escape in lung cancer evolution
The TRACERx consortium, Rosenthal, R., Cadieux, E. L., Salgado, R., Bakir, M. A., Moore, D. A., Hiley, C. T., Lund, T., Tanić, M., Reading, J. L., et al. (2019) · Nature · doi:10.1038/s41586-019-1032-7 · Cited by 946
Self-citationCo-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
Duhen, T., Duhen, R., Montler, R., Moses, J., Moudgil, T., de Miranda, N. F., Goodall, C. P., Blair, T. C., Fox, B. A., McDermott, J. E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05072-0 · Cited by 938
Turajlic, S., Litchfield, K., Xu, H., Rosenthal, R., McGranahan, N., Reading, J. L., Wong, Y. N. S., Rowan, A., Kanu, N., Al Bakir, M., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30516-8 · Cited by 911
Self-citationQuantifiable predictive features define epitope-specific T cell receptor repertoires
Dash, P., Fiore-Gartland, A. J., Hertz, T., Wang, G. C., Sharma, S., Souquette, A., Crawford, J. C., Clemens, E. B., Nguyen, T. H. O., Kedzierska, K., et al. (2017) · Nature · doi:10.1038/nature22383 · Cited by 897
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
Litchfield, K., Reading, J. L., Puttick, C., Thakkar, K., Abbosh, C., Bentham, R., Watkins, T. B. K., Rosenthal, R., Biswas, D., Rowan, A., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.002 · Cited by 893
Self-citationHellmann, M. D., Callahan, M. K., Awad, M. M., Calvo, E., Ascierto, P. A., Atmaca, A., Rizvi, N. A., Hirsch, F. R., Selvaggi, G., Szustakowski, J. D., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.04.001 · Cited by 893
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal
Turajlic, S., Xu, H., Litchfield, K., Rowan, A., Chambers, T., Lopez, J. I., Nicol, D., O’Brien, T., Larkin, J., Horswell, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.057 · Cited by 829
Self-citationAn intra-tumoral niche maintains and differentiates stem-like CD8 T cells
Jansen, C. S., Prokhnevska, N., Master, V. A., Sanda, M. G., Carlisle, J. W., Bilen, M. A., Cardenas, M., Wilkinson, S., Lake, R., Sowalsky, A. G., et al. (2019) · Nature · doi:10.1038/s41586-019-1836-5 · Cited by 817
Gene expression markers of Tumor Infiltrating Leukocytes
Danaher, P., Warren, S., Dennis, L., D’Amico, L., White, A., Disis, M. L., Geller, M. A., Odunsi, K., Beechem, J., & Fling, S. P. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0215-8 · Cited by 806
Gettinger, S., Choi, J., Hastings, K., Truini, A., Datar, I., Sowell, R., Wurtz, A., Dong, W., Cai, G., Melnick, M. A., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0593 · Cited by 787
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
Choueiri, T. K., Tomczak, P., Park, S. H., Venugopal, B., Ferguson, T., Chang, Y.-H., Hajek, J., Symeonides, S. N., Lee, J. L., Sarwar, N., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2106391 · Cited by 785
Peripheral T cell expansion predicts tumour infiltration and clinical response
Wu, T. D., Madireddi, S., de Almeida, P. E., Banchereau, R., Chen, Y.-J. J., Chitre, A. S., Chiang, E. Y., Iftikhar, H., O’Gorman, W. E., Au-Yeung, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2056-8 · Cited by 770
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
Ricketts, C. J., De Cubas, A. A., Fan, H., Smith, C. C., Lang, M., Reznik, E., Bowlby, R., Gibb, E. A., Akbani, R., Beroukhim, R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.075 · Cited by 770
Self-citationNetMHCpan, a method for MHC class I binding prediction beyond humans
Hoof, I., Peters, B., Sidney, J., Pedersen, L. E., Sette, A., Lund, O., Buus, S., & Nielsen, M. (2009) · Immunogenetics · doi:10.1007/s00251-008-0341-z · Cited by 753
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
Ricketts, C. J., De Cubas, A. A., Fan, H., Smith, C. C., Lang, M., Reznik, E., Bowlby, R., Gibb, E. A., Akbani, R., Beroukhim, R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.032 · Cited by 734
Self-citationSchietinger, A., Philip, M., Krisnawan, V. E., Chiu, E. Y., Delrow, J. J., Basom, R. S., Lauer, P., Brockstedt, D. G., Knoblaugh, S. E., Hämmerling, G. J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.011 · Cited by 720
Differentiation and Persistence of Memory CD8+ T Cells Depend on T Cell Factor 1
Zhou, X., Yu, S., Zhao, D.-M., Harty, J. T., Badovinac, V. P., & Xue, H.-H. (2010) · Immunity · doi:10.1016/j.immuni.2010.08.002 · Cited by 688
Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes
Shukla, S. A., Rooney, M. S., Rajasagi, M., Tiao, G., Dixon, P. M., Lawrence, M. S., Stevens, J., Lane, W. J., Dellagatta, J. L., Steelman, S., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3344 · Cited by 675
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal
Turajlic, S., Xu, H., Litchfield, K., Rowan, A., Horswell, S., Chambers, T., O’Brien, T., Lopez, J. I., Watkins, T. B. K., Nicol, D., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.043 · Cited by 655
Self-citationGenomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
Miao, D., Margolis, C. A., Vokes, N. I., Liu, D., Taylor-Weiner, A., Wankowicz, S. M., Adeegbe, D., Keliher, D., Schilling, B., Tracy, A., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0200-2 · Cited by 620
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
Bi, K., He, M. X., Bakouny, Z., Kanodia, A., Napolitano, S., Wu, J., Grimaldi, G., Braun, D. A., Cuoco, M. S., Mayorga, A., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.02.015 · Cited by 618
Kroeger, D. R., Milne, K., & Nelson, B. H. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2762 · Cited by 610
scRepertoire: An R-based toolkit for single-cell immune receptor analysis
Borcherding, N., & Bormann, N. L. (2020) · F1000Research · doi:10.12688/f1000research.22139.1 · Cited by 603
Powles, T., Kockx, M., Rodriguez-Vida, A., Duran, I., Crabb, S. J., Van Der Heijden, M. S., Szabados, B., Pous, A. F., Gravis, G., Herranz, U. A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0628-7 · Cited by 591
Self-citationMolecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade
Motzer, R. J., Banchereau, R., Hamidi, H., Powles, T., McDermott, D., Atkins, M. B., Escudier, B., Liu, L.-F., Leng, N., Abbas, A. R., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.10.011 · Cited by 569
Single-cell RNA-seq reveals TOX as a key regulator of CD8+ T cell persistence in chronic infection
Yao, C., Sun, H.-W., Lacey, N. E., Ji, Y., Moseman, E. A., Shih, H.-Y., Heuston, E. F., Kirby, M., Anderson, S., Cheng, J., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0403-4 · Cited by 549
Motzer, R. J., Robbins, P. B., Powles, T., Albiges, L., Haanen, J. B., Larkin, J., Mu, X. J., Ching, K. A., Uemura, M., Pal, S. K., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1044-8 · Cited by 518
Self-citationProgressive immune dysfunction with advancing disease stage in renal cell carcinoma
Braun, D. A., Street, K., Burke, K. P., Cookmeyer, D. L., Denize, T., Pedersen, C. B., Gohil, S. H., Schindler, N., Pomerance, L., Hirsch, L., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.02.013 · Cited by 504
Cancer incidence and mortality projections in the UK until 2035.
Smittenaar, C. R., Petersen, K. A., Stewart, K., & Moitt, N. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.304 · Cited by 495
Precursor exhausted T cells: key to successful immunotherapy?
Kallies, A., Zehn, D., & Utzschneider, D. T. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0223-7 · Cited by 465
Evolution of Metastases in Space and Time under Immune Selection
Angelova, M., Mlecnik, B., Vasaturo, A., Bindea, G., Fredriksen, T., Lafontaine, L., Buttard, B., Morgand, E., Bruni, D., Jouret-Mourin, A., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.018 · Cited by 457
Klapper, J. A., Downey, S. G., Smith, F. O., Yang, J. C., Hughes, M. S., Kammula, U. S., Sherry, R. M., Royal, R. E., Steinberg, S. M., & Rosenberg, S. (2008) · Cancer · doi:10.1002/cncr.23552 · Cited by 434
Krishna, C., DiNatale, R. G., Kuo, F., Srivastava, R. M., Vuong, L., Chowell, D., Gupta, S., Vanderbilt, C., Purohit, T. A., Liu, M., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.03.007 · Cited by 432
Beroukhim, R., Brunet, J.-P., Di Napoli, A., Mertz, K. D., Seeley, A., Pires, M. M., Linhart, D., Worrell, R. A., Moch, H., Rubin, M. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0146 · Cited by 412
Improved Survival with T Cell Clonotype Stability After Anti–CTLA-4 Treatment in Cancer Patients
Cha, E., Klinger, M., Hou, Y., Cummings, C., Ribas, A., Faham, M., & Fong, L. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008211 · Cited by 383
Mapping the immune environment in clear cell renal carcinoma by single-cell genomics
Borcherding, N., Vishwakarma, A., Voigt, A. P., Bellizzi, A., Kaplan, J., Nepple, K., Salem, A. K., Jenkins, R. W., Zakharia, Y., & Zhang, W. (2021) · Communications Biology · doi:10.1038/s42003-020-01625-6 · Cited by 364
Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer
Zhang, A. W., McPherson, A., Milne, K., Kroeger, D. R., Hamilton, P. T., Miranda, A., Funnell, T., Little, N., de Souza, C. P. E., Laan, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.073 · Cited by 353
Self-citationCD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor
Ye, Q., Song, D.-G., Poussin, M., Yamamoto, T., Best, A., Li, C., Coukos, G., & Powell, D. J. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0945 · Cited by 322
Classification and characterization of human endogenous retroviruses; mosaic forms are common
Vargiu, L., Rodriguez-Tomé, P., Sperber, G. O., Cadeddu, M., Grandi, N., Blikstad, V., Tramontano, E., & Blomberg, J. (2016) · Retrovirology · doi:10.1186/s12977-015-0232-y · Cited by 315
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma
Smith, C. C., Beckermann, K. E., Bortone, D. S., De Cubas, A. A., Bixby, L. M., Lee, S. J., Panda, A., Ganesan, S., Bhanot, G., Wallen, E. M., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121476 · Cited by 303
Self-citationCopynumber: Efficient algorithms for single- and multi-track copy number segmentation
Nilsen, G., Liestøl, K., Van Loo, P., Moen Vollan, H. K., Eide, M. B., Rueda, O. M., Chin, S.-F., Russell, R., Baumbusch, L. O., Caldas, C., et al. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-591 · Cited by 303
Self-citationMcDermott, D. F., Lee, J.-L., Ziobro, M., Suarez, C., Langiewicz, P., Matveev, V. B., Wiechno, P., Gafanov, R. A., Tomczak, P., Pouliot, F., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.02365 · Cited by 291
Checkpoint inhibitor immunotherapy in kidney cancer
Xu, W., Atkins, M. B., & McDermott, D. F. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0282-3 · Cited by 261
Prognostic impact of tumour‐infiltrating B cells and plasma cells in colorectal cancer
Berntsson, J., Nodin, B., Eberhard, J., Micke, P., & Jirström, K. (2016) · International Journal of Cancer · doi:10.1002/ijc.30138 · Cited by 253
TCF1 in T cell immunity: a broadened frontier
Zhao, X., Shan, Q., & Xue, H.-H. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00563-6 · Cited by 249
The Immune Biology of Microsatellite-Unstable Cancer
Kloor, M., & von Knebel Doeberitz, M. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.02.004 · Cited by 245
TOX is expressed by exhausted and polyfunctional human effector memory CD8 + T cells
Sekine, T., Perez-Potti, A., Nguyen, S., Gorin, J.-B., Wu, V. H., Gostick, E., Llewellyn-Lacey, S., Hammer, Q., Falck-Jones, S., Vangeti, S., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.aba7918 · Cited by 236
Braun, D. A., Ishii, Y., Walsh, A. M., Van Allen, E. M., Wu, C. J., Shukla, S. A., & Choueiri, T. K. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.3158 · Cited by 235
kernlab - An S4 Package for Kernel Methods in R
Hornik, K., Smola, A. J., Karatzoglou, A., et al. (2004) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 234
TRACERx consortium, Joshi, K., de Massy, M. R., Ismail, M., Reading, J. L., Uddin, I., Woolston, A., Hatipoglu, E., Oakes, T., Rosenthal, R., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0592-2 · Cited by 213
Self-citationLinsley, P. S., Speake, C., Whalen, E., & Chaussabel, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109760 · Cited by 208
Albiges, L., Powles, T., Staehler, M., Bensalah, K., Giles, R. H., Hora, M., Kuczyk, M. A., Lam, T. B., Ljungberg, B., Marconi, L., et al. (2019) · European Urology · doi:10.1016/j.eururo.2019.05.022 · Cited by 206
Biomarkers for immunotherapy in bladder cancer: a moving target
Aggen, D. H., & Drake, C. G. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0299-1 · Cited by 187
Takahashi, Y., Harashima, N., Kajigaya, S., Yokoyama, H., Cherkasova, E., McCoy, J. P., Hanada, K.-I., Mena, O., Kurlander, R., Abdul, T., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34409 · Cited by 185
Panda, A., de Cubas, A. A., Stein, M., Riedlinger, G., Kra, J., Mayer, T., Smith, C. C., Vincent, B. G., Serody, J. S., Beckermann, K. E., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.121522 · Cited by 181
Takahashi, Y., Harashima, N., Kajigaya, S., Yokoyama, H., Cherkasova, E., McCoy, J. P., Hanada, K.-I., Mena, O., Kurlander, R., Tawab, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34409c1 · Cited by 180
Fang, H., Knezevic, B., Burnham, K. L., & Knight, J. C. (2016) · Genome Medicine · doi:10.1186/s13073-016-0384-y · Cited by 172
Gulati, S., Martinez, P., Joshi, T., Birkbak, N. J., Santos, C. R., Rowan, A. J., Pickering, L., Gore, M., Larkin, J., Szallasi, Z., et al. (2014) · European Urology · doi:10.1016/j.eururo.2014.06.053 · Cited by 169
Self-citationYeong, J. P.-S., Lim, J. C. T., Lee, B. T. K., Li, H., Chia, N., Ong, C. C. H., Lye, W. K., Putti, T. C., Dent, R. A., Lim, E. H., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01209 · Cited by 157
Self-citationBenchmarking of T cell receptor repertoire profiling methods reveals large systematic biases
Barennes, P., Quiniou, V., Shugay, M., Egorov, E. S., Davydov, A. N., Chudakov, D. M., Uddin, I., Ismail, M., Oakes, T., Chain, B., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0656-3 · Cited by 157
Self-citationThe Evolutionary Origins of Recurrent Pancreatic Cancer
Sakamoto, H., Attiyeh, M. A., Gerold, J. M., Makohon-Moore, A. P., Hayashi, A., Hong, J., Kappagantula, R. L., Zhang, L., Melchor, J. P., Reiter, J. G., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1508 · Cited by 137
Indel variant analysis of short-read sequencing data with Scalpel
Fang, H., Bergmann, E. A., Arora, K. S., Vacic, V., Zody, M. C., Iossifov, I. H., O'Rawe, J., Wu, Y., Barrón, L. T. J., Rosenbaum, J., et al. (2016) · Nature Protocols · doi:10.1038/nprot.2016.150 · Cited by 134
Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell Kidney Cancer
Cherkasova, E. A., Scrivani, C., Doh, S. J., Weisman, Q., Takahashi, Y., Harashima, N., Yokoyama, H., Srinivasan, R., Linehan, W. M., Lerman, M. I., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3139 · Cited by 129
癌ゲノムアトラス 腎細胞癌の包括的分子特性化【JST・京大機械翻訳】
Christopher, J. R., Aguirre, A. D. C., Huihui, F., Christof, C. S., Martin, L. H., Reznik, E., Bowlby, R., Ewan, A. G., Akbani, R., Beroukhim, R., et al. (2018) · Cell Reports · Cited by 128
Oakes, T., Heather, J., Best, K., Byng-Maddick, R., Husovsky, C., Ismail, M., Joshi, K., Maxwell, G., Noursadeghi, M., Riddell, N. E., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01267 · Cited by 124
Self-citationParent-specific copy number in paired tumor–normal studies using circular binary segmentation
Olshen, A. B., Bengtsson, H. L., Neuvial, P., Spellman, P. T., Olshen, R. A., & Seshan, V. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr329 · Cited by 122
Best, K., Oakes, T., Heather, J., Shawe-Taylor, J. S., & Chain, B. (2015) · Scientific Reports · doi:10.1038/srep14629 · Cited by 114
Self-citationThomas, N., Heather, J., Ndifon, W. O., Shawe-Taylor, J. S., & Chain, B. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt004 · Cited by 113
Self-citationAttig, J., Young, G. R., Hosie, L., Perkins, D., Encheva-Yokoya, V., Stoye, J. P., Snijders, A. P., Ternette, N., & Kassiotis, G. (2019) · Genome Research · doi:10.1101/gr.248922.119 · Cited by 113
Self-citationEscape from nonsense-mediated decay associates with anti-tumor immunogenicity
Litchfield, K., Reading, J. L., Lim, E. L., Xu, H., Liu, P., Bakir, M. A., Wong, Y. N. S., Rowan, A., Funt, S. A., Merghoub, T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17526-5 · Cited by 113
Self-citationSpontaneous regression of metastatic renal cell carcinoma
Snow, R., & Schellhammer, P. F. (1982) · Urology · doi:10.1016/0090-4295(82)90356-9 · Cited by 112
Marafioti, T., JONES, M., Facchetti, F., Diss, T. C., Du, M.-Q., Isaacson, P. G., Pozzobon, M., Pileri, S. A., Strickson, A., Tan, S.-Y., et al. (2003) · Blood · doi:10.1182/blood-2003-03-0692 · Cited by 110
Self-citationA revised nomenclature for transcribed human endogenous retroviral loci
Mayer, J. M., Blomberg, J., & Seal, R. L. (2011) · Mobile DNA · doi:10.1186/1759-8753-2-7 · Cited by 108
The T cell differentiation landscape is shaped by tumour mutations in lung cancer
Ghorani, E., Reading, J. L., Henry, J. Y., de Massy, M. R., Rosenthal, R., Turati, V. A., Joshi, K., Furness, A. J. S., Aïssa, A. B., Saini, S. K., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0066-y · Cited by 101
Self-citationReviews Spontaneous regression of renal cell carcinoma
Janiszewska, A., Poletajew, S., & Wasiutyński, A. (2013) · Współczesna Onkologia · doi:10.5114/wo.2013.34613 · Cited by 98
Wang, Y., Hu, J., Li, Y., Xiao, M., Wang, H., Qin, T., Li, Z., Tang, J., Li, H., Tan, Y. Q., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00169 · Cited by 90
Ficial, M., Jegede, O. A., Sant’Angelo, M., Hou, Y., Flaifel, A., Pignon, J., Braun, D. A., Wind‐Rotolo, M., Sticco-Ivins, M. A., Catalano, P. J., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3084 · Cited by 89
Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors
Alaiwi, S. A., Nassar, A. H., Xie, W., Bakouny, Z., Berchuck, J. E., Braun, D. A., Baca, S. C., Nuzzo, P. V., Flippot, R., Mouhieddine, T. H., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0866 · Cited by 87
kernlab - An S4 package for kernel methods in R
Karatzoglou, A., Smola, A., Hornik, K., & Zeileis, A. (2004) · WU Research · doi:10.57938/5cc42771-15d3-4f07-ba4b-cf092a27fe21 · Cited by 79
Tumor Mutational Load and Immune Parameters across Metastatic Renal Cell Carcinoma Risk Groups
de Velasco, G., Miao, D., Voss, M. H., Hakimi, A. A., Hsieh, J. J.-D., Tannir, N. M., Tamboli, P., Appleman, L. J., Rathmell, W. K., Allen, E. M. V., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0110 · Cited by 78
Sveen, A., Løes, I. M., Alagaratnam, S., Nilsen, G., Høland, M., Lingjærde, O. C., Sørbye, H., Berg, K. C. G., Horn, A., Angelsen, J., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006225 · Cited by 74
Patterns of genomic evolution in advanced melanoma
Birkeland, E. E., Zhang, S., Poduval, D. B., Geisler, J., Nakken, S., Vodák, D., Meza‐Zepeda, L. A., Hovig, E. J., Myklebost, O., Knappskog, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05063-1 · Cited by 65
Menard, L. C., Fischer, P. A., Kakrecha, B., Linsley, P. S., Wambre, E. R., Liu, M. C., Rust, B. J., Lee, D., Penhallow, B. A., Manjarrez‐Orduño, N., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02728 · Cited by 60
Phase and context shape the function of composite oncogenic mutations
Gorelick, A. N., Rivera, F. J. S., Cai, Y., Bielski, C. M., Biederstedt, E., Jonsson, P., Richards, A. L., Vasan, N., Penson, A. V., Friedman, N. D., et al. (2020) · Nature · doi:10.1038/s41586-020-2315-8 · Cited by 46
Rahma, O. E., Ashtar, E., Ibrahim, R. A., Toubaji, A., Gause, B. L., Herrin, V. E., Linehan, W. M., Steinberg, S. M., Grollman, F., Grimes, G. J., et al. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-8 · Cited by 41
Evolving adoptive cellular therapies in urological malignancies
Wong, Y. N. S., Joshi, K., Pulè, M. A., Peggs, K. S., Swanton, C., Quezada, S. A., & Linch, M. D. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30327-3 · Cited by 38
Self-citationAttig, J., Young, G. R., Stoye, J. P., & Kassiotis, G. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02489 · Cited by 36
Self-citationKazachenka, A., Young, G. R., Attig, J., Kordella, C., Lamprianidou, E., Zoulia, E., Vrachiolias, G., Papoutselis, M. K., Bernard, E., Papaemmanuil, E., et al. (2019) · Genome Medicine · doi:10.1186/s13073-019-0707-x · Cited by 32
Self-citationSebagh, M., Allard, M., Bosselut, N., Dao, M., Vibert, É., Lewin, M., Lemoine, A., Cherqui, D., Adam, R. A., & Cunha, A. S. (2016) · Oncotarget · doi:10.18632/oncotarget.7809 · Cited by 23
Quantitative analysis of the T cell receptor repertoire
Uddin, I., Woolston, A., Peacock, T., Joshi, K., Ismail, M., Ronel, T., Husovsky, C., & Chain, B. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.05.054 · Cited by 19
Self-citationLi, X., Wang, M., & Xiang, R. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0077-2 · Cited by 13
Cited by
Immune checkpoint therapy—current perspectives and future directions
Sharma, P., Goswami, S., Raychaudhuri, D., Siddiqui, B. A., Singh, P., Nagarajan, A., Liu, J., Subudhi, S. K., Poon, C., Gant, K. L., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.006 · Cited by 1,206
Antigen presentation in cancer — mechanisms and clinical implications for immunotherapy
Yang, K., Halima, A., & Chan, T. A. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00789-4 · Cited by 321
Wang, A. Z., Mashimo, B. L., Schaettler, M. O., Sherpa, N. D., Leavitt, L. A., Livingstone, A. J., Khan, S. M., Li, M., Anzaldua-Campos, M. I., Bradley, J. D., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0913 · Cited by 73
HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy
Jiang, Q., Braun, D. A., Clauser, K. R., Ramesh, V., Shirole, N. H., Duke-Cohan, J. E., Nabilsi, N., Kramer, N. J., Forman, C., Lippincott, I. E., et al. (2025) · Cell · doi:10.1016/j.cell.2025.01.046 · Cited by 68
Metadata
- Authors
- Au, L., Hatipoglu, E., Robert de Massy, M., Litchfield, K., Beattie, G., Rowan, A., Schnidrig, D., Thompson, R., Byrne, F., Horswell, S., Fotiadis, N., Hazell, S., Nicol, D., Shepherd, S. T. C., Fendler, A., Mason, R., Del Rosario, L., Edmonds, K., Lingard, K., Sarker, S., Mangwende, M., Carlyle, E., Attig, J., Joshi, K., Uddin, I., Becker, P. D., Sunderland, M. W., Akarca, A., Puccio, I., Yang, W. W., Lund, T., Dhillon, K., Vasquez, M. D., Ghorani, E., Xu, H., Spencer, C., López, J. I., Green, A., Mahadeva, U., Borg, E., Mitchison, M., Moore, D. A., Proctor, I., Falzon, M., Pickering, L., Furness, A. J. S., Reading, J. L., Salgado, R., Marafioti, T., Jamal-Hanjani, M., Abbosh, C., Shiu, K.-K., Bridgewater, J., Hochhauser, D., Forster, M., Lee, S.-M., Ahmad, T., Papadatos-Pastos, D., Janes, S., Van Loo, P., Enfield, K., McGranahan, N., Huebner, A., Beck, S., Parker, P., Walczak, H., Enver, T., Hynds, R., Sinclair, R., Lok, C.-W., Rhodes, Z., Moore, D., Khiroya, R., Trevisan, G., Ellery, P., Linch, M., Brandner, S., Hiley, C., Veeriah, S., Razaq, M., Shaw, H., Attard, G., Akther, M. A., Naceur-Lombardelli, C., Manzano, L., Al-Bakir, M., Summan, S., Kanu, N., Ward, S., Asghar, U., Lim, E., Gishen, F., Tookman, A., Stone, P., Stirling, C., Hunter, N., Vaughan, S., Mangwende, M., Spain, L., Yan, H., Shum, B., Carlyle, E., Yousaf, N., Popat, S., Curtis, O., Stamp, G., Toncheva, A., Nye, E., Murra, A., Korteweg, J., Josephs, D., Chandra, A., Spicer, J., Stewart, R., Iredale, L.-R., Mackay, T., Deakin, B., Enting, D., Rudman, S., Ghosh, S., Karapagniotou, L., Pintus, E., Tutt, A., Howlett, S., Michalarea, V., Brenton, J., Caldas, C., Fitzgerald, R., Jimenez-Linan, M., Provenzano, E., Cluroe, A., Stewart, G., Watts, C., Gilbertson, R., McDermott, U., Tavare, S., Beddowes, E., Roxburgh, P., Biankin, A., Chalmers, A., Fraser, S., Oien, K., Kidd, A., Blyth, K., Krebs, M., Blackhall, F., Summers, Y., Dive, C., Marais, R., Gomes, F., Carter, M., Dransfield, J., Le Quesne, J., Fennell, D., Shaw, J., Naidu, B., Baijal, S., Tanchel, B., Langman, G., Robinson, A., Collard, M., Cockcroft, P., Ferris, C., Bancroft, H., Kerr, A., Middleton, G., Webb, J., Kadiri, S., Colloby, P., Olisemeke, B., Wilson, R., Tomlinson, I., Jogai, S., Ottensmeier, C., Harrison, D., Loda, M., Flanagan, A., McKenzie, M., Hackshaw, A., Ledermann, J., Chan, K., Sharp, A., Farrelly, L., Bridger, H., Kassiotis, G., Chain, B., Larkin, J., Swanton, C., Quezada, S. A., Turajlic, S., Challacombe, B., Chandra, A., Chowdhury, S., Drake, W., Fernando, A., Harrison-Phipps, K., Hazell, S., Hill, P., Horsfield, C., O'Brien, T., Olsburgh, J., Polson, A., Rudman, S., Varia, M., & Verma, H.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2021-11
- Volume
- 39
- Issue
- 11
- Pages
- 1497-1518.e11
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W3210762887
- Cited by
- 260
- References
- 155
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.